Aims Achalasia is a rare incurable neuromuscular disorder of the oesophagus. A number of treatment options are available. We reviewed our results of laparoscopic cardiomyotomy over a 30 month period.
Methods 18 patients with manometric features of achalasia underwent surgery between 2004 and 2006. Pre and postoperative weight and dysphagia scores were recorded (maximum score 45=normal, 0=complete dysphagia). Change in the Body Mass Index (BMI) was measured. Other symptoms (heartburn, epigastric pain, regurgitation, odynophagia and sleep disturbance) were scored on a 0-4 scale of increasing severity.
results At mean follow up of 16.2 months the mean dysphagia score was significantly improved from 7.5 to 33.9 (p<0.005). BMI was significantly increased from 22.3 to 25.8 kg/m 2 (p<0.05). Scores for heartburn, epigastric pain, regurgitation, odynophagia and sleep disturbance were also significantly improved. The average inpatient stay was 3.1 days and average operating time 111 minutes. One mucosal perforation occurred which was repaired intraoperatively. No patients required secondary operative intervention.
conclusions Laparoscopic cardiomyotomy is a safe, highly effective, minimally invasive treatment for achalasia.
IntroductIon
Achalasia is an incurable neuromuscular disorder of the oesophagus resulting from destruction of the oesophageal myenteric plexus. 1 This results in aperistalsis and failure of the lower oesophageal sphincter to relax following swallowing. Symptoms are gradual in onset and include dysphagia, odynophagia, regurgitation, sleep disturbance and weight loss. The annual incidence is about 1 in 100,000 people with an equal sex incidence. It tends to present in adult life between about 25 and 40 years old with less than 5% occurring in children. 2, 3 Manometry provides the definitive diagnosis. The classic features are an adynamic oesophagus, hypertensive lower oesophageal sphincter (LOS) and failure of the LOS to relax on swallowing. An oesophagogastoduodenoscopy (OGD) should also be performed to investigate for malignant disease. 4 Untreated, it leads to an extremely poor quality of life because of progressive dysphagia, oesophageal dilatation, stasis and aspiration. All current treatments are palliative and aim to reduce the pressure at the LOS. 5 Medical therapies include the use of calcium antagonists or sildenafil to relax the smooth muscle of the LOS, however results are poor. 6 Endoscopic procedures include pneumatic dilatation and injection of Botulinum Toxin. These produce acceptable short term results but long term success is limited and the majority of patients will require several interventions. 7 Surgical treatment aims to divide the muscle of the LOS longtitudinally. This can be achieved via the transabdominal, transthoracic or thoracoscopic routes. It has been suggested that the laparoscopic transabdominal route is associated with a low rate of failure and complication and a high chance of success. 8 We review here our results and experience with laparoscopic cardiomyotomy for achalasia. www.ums.ac.uk
LApAroscopIc cArdIoMyotoMy: technIque
The procedure begins with the patient in a supine position.
[ figure 1 ] The surgeon stands between the patients' legs and the assistant to the patient's left. Pneumoperitoneum is achieved by optical 10mm port insertion just below the left costal margin in the midclavicular line. An adjustable self-supporting liver retractor is inserted together with two 5mm ports and another 10mm port. The first step of the procedure is to display the oesophago-gastric junction to confirm the relevant anatomy. Then the phreno oesophageal ligament is divided with a harmonic scalpel, and the anterior oesophagus exposed. 
dysphAgIA scores
The mean dysphagia score was significantly improved. 7.5 (range 2.5-15) to 33.9 (range 18.5-45) at review (p<0.005) [ figure 5 ] 1 patient from the 18 (5.5%) had an unsatisfactory response with a dysphagia score rising only from 8.5 to 18.5 and recurrent symptoms. A gastroscopy revealed reflux oesophagitis and he is currently being managed with acid suppression.
other syMptoMs
There was a significant improvement in regurgitation, sleep disturbance, epigastric pain and odynophagia. (Table 2 ) There was no significant difference in the severity of heartburn. The effect on regurgitation appeared to be most marked, with pre operative scores improving from a mean of 3.8 to 0.8 post operatively.
dIscussIon
The most important outcome for the patient with achalasia is relief of dysphagia. Our results indicate that laparoscopic cardiomyotomy is an effective treatment for achalasia and are in keeping with the large series in the published literature. 8, 10 Our study is limited by its small size, the use of telephone to administer the questionnaire and the fact that a single investigator collected and collated the data. Previous studies have suggested that those patients with a high (>35mmHg) LOS pressure benefit much more from myotomy than those with pressures lower than this. Indeed, preoperative LOS pressure has been shown clearly to be the single strongest predictor for successful outcome. 8 This was not specifically examined for in our study. Age, sex and a history of previous pneumatic dilatation or Botulinum Toxin injection are not correlated with success or failure. 8 Evidence is accumulating that laparoscopic cardiomyotomy produces better results in the long term than pneumatic dilatation (PD). One recently reported randomized controlled trial (RCT) has addressed the issue 11 . Kostic et al found that at 12 months PD produced more treatment failures and that this trend increased with time. In addition, Vela and colleagues compared the long term efficacy of PD with that of laparoscopic cardiomyotomy. 7 They defined success in the long term as freedom from further interventions. At 6 years freedom from intervention was 28% in the single pneumatic dilatation group versus 57% in the laparoscopic cardiomyotomy patients. Indeed many patients from the PD group with more severe disease crossed over to cardiomyotomy, otherwise the difference may have been even greater. Cardiomyotomy has also previously been shown to be superior to PD in the long term. 12 There are no RCTs comparing the traditional transabdominal or transthoracic approaches with the laparoscopic procedure. There is good evidence from a well designed RCT that the addition of a Dor fundoplication reduces the risk of pathological gastrooesophageal reflux without compromising relief of dysphagia. Richards and colleagues 13 found that without a fundoplication, the incidence of pathological reflux (pH<4 for more than 4.2% of a 24 hour period) was 47%. The addition of an anterior 180 degree Dor fundoplication reduced this to 9% without any effect on post operative dysphagia or LOS pressure reduction.
Treatment failures following laparoscopic cardiomyotomy are most commonly related to inadequate myotomy, and occur more frequently on the "learning curve" phase of a surgeons training. After this, rates of failure and complication are remarkably similar between surgeons and hospitals.
14 Rates Laparoscopic cardiomyotomy is a safe, highly effective and minimally invasive treatment and many authorities consider it the first line treatment.
